In conclusion, the results of this study suggest that PDIA3 may affect the occurrence, prognosis, and treatment of a variety of cancers through its association with 11 immune cells, such as B-cell memory, plasma cells, and T-cell CD4 naive. This evidence concerns the gene CD4 and cancer.